Governance overview

The Board of Directors of UroGen® Pharma (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Governance documents

Committee charters

Committee compositions

Director Name Audit Committee Compensation Committee Compliance Committee Nominating and Corporate Governance Committee
Arie Belldegrun, M.D. Compensation Committee
Cynthia M. Butitta Audit Committee
Stuart Holden, M.D. Audit Committee Compliance Committee
Jim Robinson Compliance Committee Nominating and Corporate Governance Committee
Leana S. Wen, M.D., M.Sc. Audit Committee Nominating and Corporate Governance Committee
Daniel Wildman Compensation Committee Compliance Committee
Chairperson Member Financial Expert
View Management View Board of Directors